These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2504469)

  • 1. Electrophysiological effects of encainide and its metabolites in normal canine Purkinje fibers and Purkinje fibers surviving infarction.
    Kinnaird AA; Man RY
    Can J Physiol Pharmacol; 1989 Jul; 67(7):751-6. PubMed ID: 2504469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrophysiological effects of encainide (MJ9067) on canine subendocardial Purkinje fibers surviving infarction.
    King BW; Man RY
    J Cardiovasc Pharmacol; 1984; 6(4):547-54. PubMed ID: 6206306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological effects of encainide on isolated cardiac muscle and Purkinje fibers and on the Langendorff-perfused guinea-pig heart.
    Carmeliet E
    Eur J Pharmacol; 1980 Feb; 61(3):247-62. PubMed ID: 6767615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of encainide and its two major metabolites on cardiac conduction.
    Dresel PE
    J Pharmacol Exp Ther; 1984 Jan; 228(1):180-6. PubMed ID: 6420542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of class I anti-arrhythmic drugs in infarcted tissue.
    Man RY; Bril A
    Clin Invest Med; 1991 Oct; 14(5):466-75. PubMed ID: 1742923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophysiologic effects of encainide (MJ 9067) on canine Purkinje fibres.
    Gibson JK; Somani P; Bassett AL
    Eur J Pharmacol; 1978 Nov; 52(2):161-9. PubMed ID: 729630
    [No Abstract]   [Full Text] [Related]  

  • 7. Qualitative and quantitative comparison of the cardiac effects of encainide and its three major metabolites in the dog.
    Davy JM; Dorian P; Kantelip JP; Harrison DC; Kates RE
    J Pharmacol Exp Ther; 1986 Jun; 237(3):907-11. PubMed ID: 3086540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Electrophysiological effects of tocainide on canine subendocardial Purkinje fibers surviving infarction.
    Kinnaird AA; Man RY
    Eur J Pharmacol; 1986 May; 124(1-2):135-41. PubMed ID: 3087761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of encainide and metabolites (MJ14030 and MJ9444) on canine cardiac Purkinje and ventricular fibers.
    Elharrar V; Zipes DP
    J Pharmacol Exp Ther; 1982 Feb; 220(2):440-7. PubMed ID: 6799644
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of encainide on the determinants of cardiac excitability in sheep Purkinje fibers.
    Arnsdorf MF; Schmidt GA; Sawicki GJ
    J Pharmacol Exp Ther; 1985 Jan; 232(1):40-8. PubMed ID: 3917508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Depression of maximum rate of depolarization of guinea-pig ventricular action potentials by metabolites of encainide.
    Hemsworth PD; Campbell TJ
    Br J Pharmacol; 1989 Jun; 97(2):619-25. PubMed ID: 2503225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological effects of acetylcholine in Purkinje fibres surviving infarction.
    Bril A; Man RY
    Cardiovasc Res; 1990 Apr; 24(4):296-302. PubMed ID: 2346965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental electrophysiology of encainide and its major metabolites on the Purkinje fiber action potential.
    Case CL; Hewett KW; Gillette PC
    Biol Neonate; 1994; 66(6):330-8. PubMed ID: 7727615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of O-demethyl encainide on induced and spontaneous arrhythmias in the conscious dog.
    Dawson AK; Roden DM; Duff HJ; Woosley RL; Smith RF
    Am J Cardiol; 1984 Sep; 54(6):654-8. PubMed ID: 6475789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetically determined stereoselective excretion of encainide in humans and electrophysiologic effects of its enantiomers in canine cardiac Purkinje fibers.
    Turgeon J; Funck-Brentano C; Gray HT; Pavlou HN; Prakash C; Blair IA; Roden DM
    Clin Pharmacol Ther; 1991 May; 49(5):488-96. PubMed ID: 1903098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiology of O-demethyl encainide in a canine model of sustained ventricular tachycardia.
    Roden DM; Dawson AK; Duff HJ; Woosley RL; Smith RF
    J Cardiovasc Pharmacol; 1984; 6(4):588-95. PubMed ID: 6206311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiological actions of flecainide in normal and infarcted canine Purkinje fibers.
    Kinnaird AA; Lederman CL; Man RY
    Eur J Pharmacol; 1985 May; 112(1):57-64. PubMed ID: 4018138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrophysiological effects of carocainide (770207) on canine ventricular muscle and Purkinje fibers.
    Pourrias B; Santamaria R
    Arch Int Pharmacodyn Ther; 1983 Sep; 265(1):85-95. PubMed ID: 6316863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiarrhythmic activity of the O-demethyl metabolite of encainide.
    Roden DM; Duff HJ; Altenbern D; Woosley RL
    J Pharmacol Exp Ther; 1982 Jun; 221(3):552-7. PubMed ID: 6806461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrophysiologic actions of O-demethyl encainide: an active metabolite.
    Duff HJ; Dawson AK; Roden DM; Oates JA; Smith RF; Woosley RL
    Circulation; 1983 Aug; 68(2):385-91. PubMed ID: 6861313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.